Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection

NCT04431414 is registered in ClinicalTrials.gov with COVID-19 Prevention Network as lead sponsor.

NCT NCT04431414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04431414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection
Lead sponsor
COVID-19 Prevention Network
Phase
Observational
Overall status
Completed
Start date
July 20, 2020
Completion date
June 2, 2022
Enrollment
953 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2